287 related articles for article (PubMed ID: 11016148)
21. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
22. Visual inspection of the cervix as a primary means of cervical cancer screening: results of a pilot study.
Chirenje ZM; Chipato T; Kasule J; Rusakaniko S
Cent Afr J Med; 1999 Feb; 45(2):30-3. PubMed ID: 10444896
[TBL] [Abstract][Full Text] [Related]
23. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
24. Cervical cancer: screening and therapeutic perspectives.
Sankaranarayanan R; Thara S; Esmy PO; Basu P
Med Princ Pract; 2008; 17(5):351-64. PubMed ID: 18685274
[TBL] [Abstract][Full Text] [Related]
25. Comparison of visual inspection of cervix and Pap smear for cervical cancer screening.
Tayyeb R; Khawaja NP; Malik N
J Coll Physicians Surg Pak; 2003 Apr; 13(4):201-3. PubMed ID: 12718787
[TBL] [Abstract][Full Text] [Related]
26. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
27. Downstaging for cervical cancer: a community-based study in the rural areas of Udupi district, Karnataka, India.
Rao RS; Kamath VG; Chandrashekhar S; Rao L; Pratap K
Trop Doct; 2007 Apr; 37(2):73-5. PubMed ID: 17540082
[TBL] [Abstract][Full Text] [Related]
28. Direct visual inspection of the cervix with Lugol iodine for the detection of premalignant lesions.
El-Shalakany AH; Saeed MM; Abdel-Aal MR; El-Nakeeb AH; Noseirat N; Ayyad SB; El Din ZS
J Low Genit Tract Dis; 2008 Jul; 12(3):193-8. PubMed ID: 18596460
[TBL] [Abstract][Full Text] [Related]
29. Worldwide early detection of cervical cancer.
Lunt R
Obstet Gynecol; 1984 May; 63(5):708-13. PubMed ID: 6717875
[TBL] [Abstract][Full Text] [Related]
30. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
31. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
32. The facilities and challenges for cancer control in India.
Desai PB
Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1146-52. PubMed ID: 1514827
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of downstaging in the detection of cervical neoplasia in Kolkata, India.
Basu P; Sankaranarayanan R; Mandal R; Roy C; Das P; Choudhury D; Datta K; Karamakar S; Tsu V; Chakrabarti RN; Siddiqi M;
Int J Cancer; 2002 Jul; 100(1):92-6. PubMed ID: 12115593
[TBL] [Abstract][Full Text] [Related]
34. Papanicolaou screening in developing countries: an idea whose time has come.
Suba EJ; Raab SS;
Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
[TBL] [Abstract][Full Text] [Related]
35. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
36. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
37. [Progress in the early detection of cervix cancer from the viewpoint of the Saarland cancer register].
Brenner H; Wiebelt H; Ziegler H
Geburtshilfe Frauenheilkd; 1990 Apr; 50(4):304-9. PubMed ID: 2358181
[TBL] [Abstract][Full Text] [Related]
38. Women and cancer.
Stanley K; Stjernswärd J; Koroltchouk V
World Health Stat Q; 1987; 40(3):267-78. PubMed ID: 3500549
[TBL] [Abstract][Full Text] [Related]
39. Estimation of reduction of life-time risk of cervical cancer through one life-time screening.
Murthy NS; Agarwal SS; Prabhakar AK; Sharma S; Das DK
Neoplasma; 1993; 40(4):255-8. PubMed ID: 8272152
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a hospital based cytology screening program.
Das DK; Murthy NS; Bhatnager P; Juneja A; Sharma S; Pant JN; Bhatt NC; Sharma KC; Luthra UK
Neoplasma; 1992; 39(6):381-4. PubMed ID: 1491729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
